Our proprietary ultra-low radio frequency energy (ulRFE®) technology produces a cognate by measuring and recording the oscillating magnetic field produced by molecules in solution. The ulRFE cognate is delivered locally and non-systemically via a medical device. Pre-clinical and clinical studies suggest the ability to specifically regulate metabolic pathways and replicate known mechanisms of action for proven commercial drugs.
Note: EMulate Therapeutics Voyager® ulRFE® system for GBM is an investigational medical device. Limited by United States law to investigational use only.
Every molecule has a unique electrostatic potential. The electrostatic potential is critically important to the chemical properties of a molecule and how a molecule interacts with, and in, a biological system. Our ‘Super Conducting Quantum Interference Device’ (SQUID) based technology measures the unique electrostatic potential of a molecule, as specific Radio Frequency Energy (RFE). This unique and specific RFE is used to induce electron and charge transfer in a defined bioactive target, altering cell dynamics to produce a therapeutic response.